InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019)

InfuSystem Holdings (INFU) posted Total Non-Current Liabilities of $52.1 million for Q2 2019, up 9.7% on a QoQ basis from $47.5 million in Q1 2019, and up 53.89% year-over-year from $33.9 million in Q2 2018.

InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019) Analysis & Trends

InfuSystem Holdings' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $52.1 million for Q2 2019.

  • Quarterly Total Non-Current Liabilities rose 53.89% year-over-year to $52.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $52.1 million (up 53.89% YoY) and the FY2018 annual result came in at $43.6 million, up 15.04% from the prior year.
  • Total Non-Current Liabilities was $52.1 million for Q2 2019 at InfuSystem Holdings, up from $47.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $52.1 million in Q2 2019 and bottomed at $2.1 million in Q1 2017.
  • A 5-year average of $34.1 million and a median of $33.8 million in 2018 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2016 — Total Non-Current Liabilities declined 1.9% — and 2018, when it soared 1471.9%.
  • InfuSystem Holdings' Total Non-Current Liabilities stood at $29.8 million in 2015, then decreased by 1.9% to $29.2 million in 2016, then rose by 29.82% to $37.9 million in 2017, then climbed by 15.04% to $43.6 million in 2018, then rose by 19.43% to $52.1 million in 2019.
  • Business Quant data shows INFU's Total Non-Current Liabilities at $52.1 million in Q2 2019, $47.5 million in Q1 2019, and $43.6 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 InfuSystem Holdings 179.47 Mn 177.37 Mn 19.68 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 52.11 Mn
Mar 31, 2019 47.50 Mn
Dec 31, 2018 43.63 Mn
Sep 30, 2018 43.39 Mn
Jun 30, 2018 33.86 Mn
Mar 31, 2018 33.73 Mn
Dec 31, 2017 37.93 Mn
Sep 30, 2017 26.64 Mn
Jun 30, 2017 29.02 Mn
Mar 31, 2017 2.15 Mn
Dec 31, 2016 29.22 Mn
Dec 31, 2015 29.78 Mn
Sep 30, 2013 34.77 Mn
Jun 30, 2013 34.94 Mn
Mar 31, 2013 35.70 Mn
Dec 31, 2012 37.51 Mn
Mar 31, 2012 35.62 Mn
Dec 31, 2011 35.68 Mn
Sep 30, 2011 38.36 Mn
Jun 30, 2011 36.01 Mn